Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment
Clinical trial NCT02061085 · COMPLETED
Trial details
- NCT number
- NCT02061085
- Sponsor
- MedSIR
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-12-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.